| Medical Mutual | Tecartus® (brexucabtagene autoleucel) (Intravenous) | 2025-11-04 |
| Medical Mutual | Xiaflex® (collagenase) (Intralesional) | 2025-11-04 |
| Medical Mutual | Zepzelca® (lurbinectedin) (Intravenous) | 2025-11-04 |
| BCBS Minnesota | Wheelchairs - Mobility Assistive Equipment | 2025-11-03 |
| BCBS Minnesota | Panniculectomy/Excision of Redundant Skin or Tissue | 2025-11-03 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Outpatient Pulmonary Rehabilitation | 2025-11-03 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers) | 2025-11-03 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Trastuzumab (Herceptin), Trastuzumab Biosimilars, and Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) | 2025-11-03 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Treatment of Hereditary Angioedema (HAE) | 2025-11-03 |
| BCBS Highmark Penn Medicare Advantage | Trastuzumab (Herceptin), Trastuzumab Biosimilars, and Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta) | 2025-11-03 |